MALT1-IN-11
MALT1-IN-11 (Example 151 in reference Patent) is a MALT1 protease inhibitor (IC50 IC50 of 10-100 nM. MALT1-IN-11 can be used for the research of cancer, autoimmune and inflammatory disorders[1].
Product Specifications
CAS Number
[2812352-99-9]
UNSPSC
12352005
Target
MALT1
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/malt1-in-11.html
Solubility
10 mM in DMSO
Smiles
CC1(C2=C(C=NC3=CC(F)=NN32)[C@H](C1)C(NC4=CN=C(N5N=CC=N5)C(C(F)(F)F)=C4)=O)C
Molecular Formula
C20H16F4N8O
Molecular Weight
460.39
References & Citations
[1]Shulu FENG, et al. Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disoders. Patent. WO2022164789.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human SERPINI1 shRNA (UAS) - Lentiviral human SERPINI1 shRNA (UAS) (100)
LAMP2, CT (LAMP2, Lysosome-associated membrane glycoprotein 2, CD107 antigen-like family member B, CD107b) (APC)
LAMP2, CT (LAMP2, Lysosome-associated membrane glycoprotein 2, CD107 antigen-like family member B, CD107b) (APC)